Prediction of new organ onset in recurrent immunoglobulin G4-related disease during 10 years of follow-up.
Zheng LiuYu PengJieqiong LiHui LuLinyi PengJiaxin ZhouShuang ZhouCan HuangMu WangLiang ZhuHua ChenLi WangYunyun FeiYan ZhaoXiaofeng ZengWen ZhangPublished in: Journal of internal medicine (2022)
About one third of IgG4-RD patients with relapse suffer from NOI. We developed a risk stratification model that can effectively predict the future risk of NOI. Glucocorticoid and IM combined therapy during maintenance is also recommended.